Jesse Kuiper
Overview
Explore the profile of Jesse Kuiper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stiving A, Roose B, Tubbs C, Haverick M, Gruber A, Rustandi R, et al.
NPJ Vaccines
. 2025 Feb;
10(1):38.
PMID: 39988579
The success of mRNA-based therapeutics and vaccines is attributed to their rapid development, adaptability, and scalable production. Modified ribonucleotides like N-methylpseudouridine enhance stability and reduce immunogenicity but were recently found...
2.
Baxevanis F, Zarmpi P, Kuiper J, Fotaki N
Eur J Pharm Sci
. 2020 Feb;
146:105263.
PMID: 32061656
The presence of fat in the gastric environment can affect the pharmacokinetic behaviour of drugs with mechanisms which have not been yet fully understood. The objective of the current study...
3.
Abend A, Curran D, Kuiper J, Lu X, Li H, Hermans A, et al.
AAPS J
. 2019 Jan;
21(2):21.
PMID: 30690680
This publication summarizes the proceedings and key outcomes of the first day ("Day 1") of the 3-day workshop on "Dissolution and Translational Modeling Strategies Enabling Patient-Centric Product Development." The overall...
4.
Francis A, Nguyen T, Lamm M, Teller R, Forster S, Xu W, et al.
Mol Pharm
. 2018 Oct;
15(12):5793-5801.
PMID: 30362772
Localized drug delivery systems (DDSs) provide therapeutic levels of drug agent while mitigating side effects of systemic delivery. These systems offer controlled release over extended periods of time making them...
5.
Baxevanis F, Kuiper J, Fotaki N
Eur J Pharm Biopharm
. 2018 Aug;
131:178-188.
PMID: 30110669
In this study, the influence of the presence of excipients in sample preparation and clean-up steps required prior to drug analysis in milk-based media which simulate the in vivo properties...
6.
Baxevanis F, Kuiper J, Fotaki N
Eur J Pharm Biopharm
. 2018 Mar;
127:326-341.
PMID: 29510204
Milk-based media such as the Fed State Simulated Gastric Fluid (FeSSGF) are commonly used in order to simulate the in vivo properties of the fed state stomach. Due to the...
7.
Baxevanis F, Kuiper J, Fotaki N
Eur J Pharm Biopharm
. 2016 Jul;
107:234-48.
PMID: 27422208
Gastric fed state conditions can have a significant effect on drug dissolution and absorption. In vitro dissolution tests with simple aqueous media cannot usually predict drugs' in vivo response, as...